Transition From Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype
ACR Open Rheumatology · 2026-03 · 8 (3)
DOI: 10.1002/acr2.90001 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACR Open Rheumatology, online erschienen am 26.02.2026. Verfasst von Austen Grooms und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, William Beaumont University Hospital, Royal Oak, Michigan. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Juvenile dermatomyositis (JDM) is a rare childhood inflammatory myopathy, whereas spondyloarthritis (SpA) is an inflammatory arthropathy characterized by enthesitis and peripheral or axial involvement. We describe a series of patients diagnosed with JDM in childhood who later fulfilled classification criteria for SpA, a sequential phenotype that has not been well characterized.
Methods
This institutional review board–exempt retrospective study (2024‐180) reviewed demographics, clinical features, laboratory tests, imaging, treatments, and outcomes in a convenience sample of patients who met criteria for JDM before age 18 and subsequently fulfilled the Assessment of Spondyloarthritis International Society (ASAS) or Classification for Psoriatic Arthritis (CASPAR) criteria. Patients with SpA preceding JDM were excluded. Descriptive statistics were used to explore potential predictors of SpA development.
Results
Seven patients met the inclusion criteria; 57% were female and 86% were White. The median age at JDM diagnosis was 8 years (interquartile range [IQR] 5–10 years). The median interval time to SpA diagnosis was 7 years (IQR 5–14 years). All tested patients had elevated neopterin and magnetic resonance imaging evidence of myositis; 71% experienced complications before SpA onset. All met ASAS criteria for peripheral SpA, and 29% met CASPAR criteria. HLA‐B27 was positive in 20% of those tested. Most (83%) responded to standard SpA therapies; one required rituximab and azathioprine for calcinosis.
Conclusion
This preliminary small study highlights a possible evolution from JDM, an adaptive immune disease, to SpA, an innate‐driven illness. These findings suggest potential predictors of disease overlap and warrant future studies to clarify mechanisms and inform predictive models.
Autor:innen und Institutionen
- Department of Pediatrics, William Beaumont University Hospital, Royal Oak, Michigan.
- Department of Medicine, William Beaumont University Hospital, Royal Oak, Michigan.
- River City Rheumatology, Ada, Michigan.
ORCID-Profile: Austen Grooms
Zitieren
APA
Grooms, A., Karageorgiou, I., Mychaliska, K., & Birmingham, J. (2026). Transition From Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype. ACR Open Rheumatology, 8(3). https://doi.org/10.1002/acr2.90001
Vancouver
Grooms A, Karageorgiou I, Mychaliska K, Birmingham J. Transition From Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype. ACR Open Rheumatology. 2026;8(3). doi:10.1002/acr2.90001
BibTeX
@article{Grooms2026,
author = {Grooms, Austen and Karageorgiou, Ioannis and Mychaliska, Kerry and Birmingham, James},
title = {Transition From Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype},
journal = {ACR Open Rheumatology},
year = {2026},
volume = {8},
number = {3},
doi = {10.1002/acr2.90001}
}
EUVIMED